Magnetic electrochemical sensing platform for biomonitoring of exposure to organophosphorus pesticides and nerve agents based on simultaneous measurement of total enzyme amount and enzyme activity
-
2011/05/15
Details
-
Personal Author:
-
Description:We report a new approach for electrochemical quantification of enzymatic inhibition and phosphorylation for biomonitoring of exposure to organophosphorus (OP) pesticides and nerve agents based on a magnetic bead (MB) immunosensing platform. The principle of this approach is based on the combination of MB immunocapture-based enzyme activity assay and competitive immunoassay of the total amount of enzyme for simultaneous detection of enzyme inhibition and phosphorylation in biological fluids. Butyrylcholinesterase (BChE) was chosen as a model enzyme. In competitive immunoassay, the target BChE in a sample competes with the BChE immobilized on the MBs to bind to the limited sites of anti-BChE antibody labeled with quantum dots (QD-anti- BChE), followed by stripping voltammetric analysis of the bound QD conjugate on the MBs. This assay shows a linear response over the total BChE concentration range of 0.1-20 nM. Simultaneous real time BChE activity was measured on an electrochemical carbon nanotube-based sensor coupled with a microflow injection system after immunocapture by the MB-anti-BChE conjugate. Therefore, the formed phosphorylated BChE adduct (OP-BChE) can be estimated by the difference values of the total amount of BChE (including active and OP-inhibited) and active BChE from established calibration curves. This approach not only eliminates the difficulty in screening of low-dose OP exposure (less than 20% inhibition of BChE) because of individual variation of BChE values but also avoids the drawback of the scarce availability of OP-BChE antibody. It is sensitive enough to detect 0.5 nM OP-BChE, which is less than 2% BChE inhibition. This method offers a new method for rapid, accurate, selective, and inexpensive quantification of OP-BChE and enzyme inhibition for biomonitoring of OP and nerve agent exposures. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0003-2700
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Volume:83
-
Issue:10
-
NIOSHTIC Number:nn:20039542
-
Citation:Anal Chem 2011 May; 83(10):3770-3777
-
Contact Point Address:Jun Wang, Pacific Northwest National Laboratory, Richland, WA 99352, USA
-
Email:jun.wang@pnl.gov
-
Federal Fiscal Year:2011
-
NORA Priority Area:
-
Performing Organization:Battelle Pacific Northwest Laboratories
-
Peer Reviewed:True
-
Start Date:20060901
-
Source Full Name:Analytical Chemistry
-
End Date:20170831
-
Collection(s):
-
Main Document Checksum:urn:sha-512:67e8cd38607fb9c4c4d3fdde497559733f82de6682a650dbafb510271c7d9163bc558d83c7f1a882a986624157cea7be490c9eed434d0bbb9d27a3d6273d5edf
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like